Seed VC · San Francisco
1955 Capital
What they invest in
1955 Capital focuses on the translational gap between scientific discovery and company building, investing before markets are obvious in breakthrough technologies across biology, materials, and computation. The firm works closely with founders and scientists to turn early discoveries into real companies.
Who they back
Business models
deeptech_ip, hardware, biotech_therapeutics
Customer segments
Enterprise, Healthcare Providers, Industrial, Government
Geography
US
Recent investments
- Nature's Fynd
- Noah Medical
- Gridtential
+ 3 more deals. Score your deck to see the full investment history.
The people who write checks
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Why this firm matters for fundraising founders
1955 Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks 1955 Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
At a glance
- Website
- www.1955.capital ↗
Other firms investing in Climate Tech
See all investors
Is 1955 Capital the right fit for your deck?
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. 1955 Capital is one of them — and we'll tell you exactly where they sit in your top 100.